Altimmune (ALT) Current Deferred Revenue (2011 - 2018)
Altimmune's (ALT) quarterly Current Deferred Revenue came in at $173952.0 in Q3 2018, up 780.64% year-on-year from $19753.0 in Q3 2017, and up 0.89% on a QoQ basis from $172414.0 in Q2 2018.
Altimmune (ALT) Current Deferred Revenue (2011 - 2018) Analysis & Trends
Altimmune (ALT) has 7 years of Current Deferred Revenue data on file, last reported at $173952.0 in Q3 2018.
- On a quarterly basis, Current Deferred Revenue rose 780.64% year-over-year to $173952.0 in Q3 2018; TTM through Sep 2018 was $173952.0, a 780.64% increase from a year earlier, with the FY2017 full-year figure at $15914.0, down 19.44% from the prior year.
- Current Deferred Revenue for Q3 2018 stood at $173952.0, up from $172414.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for ALT reached as high as $173952.0 in Q3 2018 and fell as low as $15914.0 in Q4 2017.
- Historically, Current Deferred Revenue has averaged $67631.6 across 4 years, with a median of $38503.0 in 2017.
- Across the five-year window, Current Deferred Revenue plunged 92.88% in 2014 and surged 780.64% in 2018, its largest moves.
- Year by year, Current Deferred Revenue stood at $62261.0 in 2014, then sank by 68.27% to $19753.0 in 2016, then fell by 19.44% to $15914.0 in 2017, then surged by 993.08% to $173952.0 in 2018.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $173952.0 in Q3 2018, $172414.0 in Q2 2018, and $44753.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 173,952.00 |
| Jun 30, 2018 | 172,414.00 |
| Mar 31, 2018 | 44,753.00 |
| Dec 31, 2017 | 15,914.00 |
| Sep 30, 2017 | 19,753.00 |
| Jun 30, 2017 | 32,253.00 |
| Dec 31, 2016 | 19,753.00 |
| Mar 31, 2014 | 62,261.00 |
| Dec 31, 2013 | 341,723.00 |
| Sep 30, 2013 | 471,816.00 |
| Jun 30, 2013 | 508,175.00 |
| Mar 31, 2013 | 874,404.00 |
| Dec 31, 2012 | 1.38 Mn |
| Dec 31, 2011 | 514,312.00 |